Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.
Schwab N, Schneider-Hohendorf T, Posevitz V, Breuer J, Göbel K, Windhagen S, Brochet B, Vermersch P, Lebrun-Frenay C, Posevitz-Fejfár A, Capra R, Imberti L, Straeten V, Haas J, Wildemann B, Havla J, Kümpfel T, Meinl I, Niessen K, Goelz S, Kleinschnitz C, Warnke C, Buck D, Gold R, Kieseier BC, Meuth SG, Foley J, Chan A, Brassat D, Wiendl H. Schwab N, et al. Among authors: goelz s. Neurology. 2013 Sep 3;81(10):865-71. doi: 10.1212/WNL.0b013e3182a351fb. Epub 2013 Aug 7. Neurology. 2013. PMID: 23925765
Changes to anti-JCV antibody levels in a Swedish national MS cohort.
Warnke C, Ramanujam R, Plavina T, Bergström T, Goelz S, Subramanyam M, Kockum I, Rahbar A, Kieseier BC, Holmén C, Olsson T, Hillert J, Fogdell-Hahn A. Warnke C, et al. Among authors: goelz s. J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1199-205. doi: 10.1136/jnnp-2012-304332. Epub 2013 Mar 5. J Neurol Neurosurg Psychiatry. 2013. PMID: 23463870 Free PMC article.
Functional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disorders.
Haghikia A, Perrech M, Pula B, Ruhrmann S, Potthoff A, Brockmeyer NH, Goelz S, Wiendl H, Lindå H, Ziemssen T, Baranzini SE, Käll TB, Bengel D, Olsson T, Gold R, Chan A. Haghikia A, et al. Among authors: goelz s. PLoS One. 2011 Apr 20;6(4):e18506. doi: 10.1371/journal.pone.0018506. PLoS One. 2011. PMID: 21533133 Free PMC article. Clinical Trial.
Anti-JC virus antibodies: implications for PML risk stratification.
Gorelik L, Lerner M, Bixler S, Crossman M, Schlain B, Simon K, Pace A, Cheung A, Chen LL, Berman M, Zein F, Wilson E, Yednock T, Sandrock A, Goelz SE, Subramanyam M. Gorelik L, et al. Among authors: goelz se. Ann Neurol. 2010 Sep;68(3):295-303. doi: 10.1002/ana.22128. Ann Neurol. 2010. PMID: 20737510
Neutralizing antibodies and efficacy of interferon beta-1a: a 4-year controlled study.
Kappos L, Clanet M, Sandberg-Wollheim M, Radue EW, Hartung HP, Hohlfeld R, Xu J, Bennett D, Sandrock A, Goelz S; European Interferon Beta-1a IM Dose-Comparison Study Investigators. Kappos L, et al. Among authors: goelz s. Neurology. 2005 Jul 12;65(1):40-7. doi: 10.1212/01.wnl.0000171747.59767.5c. Neurology. 2005. PMID: 16009883 Clinical Trial.
74 results